Temsirolimus
Temsirolimus
ATX: L01EG01
Pharmacological group: Protein kinase inhibitors (mTOR-kinase inhibitors)
Drug form: Concentrate for solution for infusion with diluent in 2,2ml vial
Dosage and pack size: 30mg/1,2ml in vials in package №1
Indication: Treatment of renal cell carcinoma (RCC) by inhibiting mTOR